Human Papillomavirus (HPV) Nucleic Acid Detection Kit (Hybrid Capture-CLIA)

Human Papillomavirus (HPV) Nucleic Acid Detection Kit (Hybrid Capture-CLIA)

Tests
Human Papillomavirus (HPV) Nucleic Acid Detection Kit (Hybrid Capture-CLIA)
Human Papillomavirus (HPV) Nucleic Acid Detection Kit (Hybrid Capture-CLIA)

Information

an in vitro nucleic hybridization assay. using a new generation hybrid capture technology for the qualitative detection of 14 high-risk types of human papillomavirus (HPV) in cervical specimens. The HPV types detected by the assay are the high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68
Hangzhou Dalton BioSciences, LTD.H6.E36DALTON BioSciences ("DALTONbio") is an innovative global medical technology company focusing on in vitro diagnosis (IVD) in women's health, oncology, and infectious diseases. Our quality system has been certified by ISO13485 and MDSAP. Investing in cutting-edge technologies and molecular biology, DALTONbio has established leading positions in clinical diagnosis and screening of cervical cancer and endometrial carcinoma. We are committed to people's health, particularly women's well-being, through investing in our people, in science & technology, and in various initiatives for the world. We have served the health of nearly 30 million women thus far.

Log in